A compounded peptide is not an unregulated one. The substance, the pharmacy that prepares it, and the purpose it's prescribed for all sit under FDA oversight. Done correctly, compounding is a long-standing, lawful part of medicine. Done outside the framework, it carries real compliance risk. The difference is worth understanding.

What the FDA governs

Three things determine whether a compounded peptide is on solid ground:

The FDA maintains lists that decide which substances may be used. The 503A Bulks List is the central one: it defines the bulk drug substances a 503A pharmacy may compound with. Prescribing outside of these frameworks — reaching for a substance that isn't permitted — introduces compliance risk, however the prescription is framed.

How it must be made

Permitted substances are only half of it. A compounded medication must also be prepared by a licensed pharmacy following the standards that govern preparation:

These are not formalities. They are the difference between a sterile, correctly prepared injectable and one that isn't — and the reason the pharmacy you work with matters as much as the molecule.

Understanding these frameworks is what keeps a prescription aligned with both the law and the patient's safety.

This is the standard we hold our pharmacy partners to, and the reason we state it plainly: U.S.-licensed pharmacies, ingredients from FDA-registered facilities, and rigorous independent third-party quality testing. The framework exists to protect the patient. We would rather operate inside it — and tell you that we do.

This entry is educational and reflects the standards Zashel holds. It is not legal or medical advice.

← All entries